BAXTER INTERNATIONAL INC

Surgical & Medical Instruments & Apparatus·DEERFIELD, IL·FY end 12/31·CIK 10456

Overview Financials Compensation Governance Insiders Filings

Board of Directors

10 members · 9 independent · FY 2024

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
William A. Ampofo II	Director	2y	51	Quality and Regulatory ComplianceOperating		$324,986
Jeffrey A. Craig	Director	1y	64	Audit		$173,540
Patricia B. Morrison	Director	6y	65	AuditNCGOperating		$349,482
Stephen N. Oesterle	Director	8y	74	NCGQuality and Regulatory Compliance		—
Stephen H. Rusckowski	Director	2y	67	CompQuality and Regulatory ComplianceOperating		$354,986
Nancy M. Schlichting	Lead Independent Director	4y	70	CompQuality and Regulatory Compliance		$369,521
Brent Shafer	CEO and Director	3y	67	—	—	$386,986
Cathy R. Smith	Director	8y	61	AuditNCG		$359,986
Amy A. Wendell	Director	6y	64	CompQuality and Regulatory ComplianceOperating		$354,986
David S. Wilkes	Director	4y	68	NCGQuality and Regulatory Compliance		—

Risk-factor diff

FY 2025 10-K vs. FY 2024

+271 new−302 removed

Net-new paragraphs in the most recent 10-K's Item 1A. Companies rarely add risk language without a real reason — additions here are often a leading signal of management concerns.

NEW · FY 2025

“Currency translation adjustments, net of tax expense (benefit) of ($”

NEW · FY 2025

“Currency translation adjustments, net of tax expense (benefit) of”

NEW · FY 2025

“Reclassification of other comprehensive income (loss) disposed in the Kidney Care separation”

NEW · FY 2025

“Disposition of noncontrolling interest associated with the Kidney Care separation”

NEW · FY 2025

“Cash flows from (used in) operations – discontinued operations”

+ 25 more new paragraphs not shown

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.